Nevertheless, in T2DM patients under glycemic control (in particular, when using insulin analogues), the epidemiological analyses have shown enhanced risk of developing cancer in breast, kidney, colon, prostate and pancreas [34]. Here, INS is linked to type 2 diabetes mellitus.